Jefferies Group's position in Lyra Therapeutics is currently worth $3.76 Thousand. That's 0.00% of their equity portfolio (1013th largest holding). The investor's estimated purchase price is $60.7 Thousand, resulting in a loss of 94%.
Avg closing price
Price range
New holding (+11.4 Thousand shares)
Q1 2024
Avg closing price
$5.33
Price range
$4.55
-
$6.53
News about Lyra Therapeutics Inc and Jefferies Group